Results for tag: "Oral Solid Dosage Excipients"

The oral solid dosage excipients market refers to the segment of pharmaceutical intermediates that specializes in the supply of inert substances used in tablet and capsule formulations. Excipients play a crucial role in the manufacturing process, ensuring that active pharmaceutical ingredients (APIs) can be effectively processed into oral solid dosages, which are the most common form of medication delivery. They serve various functions such as bulking agents, binders, coatings, disintegrants, and lubricants, ensuring the stability, bioavailability, and controlled release of APIs within the human body. The evolution of this market reflects the pharmaceutical industry's continuing efforts to enhance drug performance, patient compliance, and manufacturing efficiency. R&D advancements and the advent of novel excipients have broadened the scope of oral solid dosage forms, leading to more sophisticated and targeted drug delivery systems. Regulatory considerations also shape the market, as excipients must comply with strict standards for safety and efficacy. Companies in the oral solid dosage excipients market include Dow Chemical Company, Ashland Global Holdings Inc., BASF SE, Roquette Frères, DuPont de Nemours, Inc., JRS PHARMA, and Evonik Industries AG. They offer a range of products and services aimed at assisting pharma companies with the development and production of oral solid dosage medications, leveraging their expertise in material science and chemistry. Show Less Read more